ROBINSON CHANDLER (Chief Executive Officer) exercised options at MONOPAR THERAPEUTICS
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 1/5/2026ACC: 0001437749-26-000306
DirectorOfficer10% Owner· Chief Executive Officer
Since Aug 2018
-2.56K
Net shares
Net seller
$167.0K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
8.72K acquired · 11.28K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+8.72K
Price / share
—
Trade value
—
% of position
11.0%
12/31/2025
79.55K→88.28K
Common Stock
Direct
Shares
−2.56K
Price / share
$65.30
Trade value
$167.04K
% of position
2.9%
12/31/2025
88.28K→85.72K
Total
Net shares
+6.17K
Net value
-$167.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/31/2025 | M · Option Exercise | +8.72K | — | — | 11.0% | 79.55K | 88.28K |
| Common Stock Direct | 12/31/2025 | F · Tax Withholding | −2.56K | $65.30 | $167.04K | 2.9% | 88.28K | 85.72K |
| Total | +6.17K | -$167.04K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
8.72K shares
Shares
−8.72K
Strike price
Held after
113.01K
Exercisable
—
12/31/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock8.72K shares | 12/31/2025 | M · Option Exercise | −8.72K | — | 113.01K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned272.03K
Total
272.03K indirect272.03K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 272.03K | Indirect |
| Total | 272.03K | 272.03K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported